Evaluation of patients with liver metastases from colorectal cancer for locally ablative treatment with laser induced thermotherapy: Impact of PET with18F-fluorodeoxyglucose on therapeutic decisions

NuklearMedizin

Volumn 45, Issue 4, 2006, Pages 177-184

  Amthauer, Holger ^a   Denecke, T ^a   Hildebrandt, B ^a   Ruhl R ^a   Miersch, A ^a   Nicolaou, A ^a   Ruf, J ^a   Plotkin, M ^a   Hanninen E L ^a   Stroszczynski, C ^a   Gutberlet, M ^a   Langrehr, J ^a   Riess, H ^a   Ricke, J ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Colorectal cancer; Laser induced thermotherapy; Liver metastases; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE;

ARTICLE; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LIVER METASTASIS; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; POSITRON EMISSION TOMOGRAPHY;

EID: 33748546570     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1625115     Document Type: Article

References (34)

1. Adam R, Avisar E, Ariche A et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 2001; 8: 347-53.
2. Akhurst T, Kates TJ, Mazumdar M et al. Recent chemotherapy reduces the sensitivity of 18Fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases. J Clin Oncol 2005; 23: 8713-6.
3. Arulampalam TH, Francis DL, Visvikis D et al. FDG-PET for the pre-operative evaluation of colorectal liver metastases. Eur J Surg Oncol 2004; 30: 286-91.
4. Berber E, Pelley R, Siperstein AE. Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study. J Clin Oncol 2005; 23: 1358-64.
5. Bipat S, Leeuwen MS, Comans EF et al. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis-meta-analysis. Radiology 2005; 237: 123-31.
6. Delbeke D, Vitola JY, Sandler MP et al. Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med 1997; 38: 1196-201.
7. Denecke T, Rau B, Hoffmann KT et al. Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: Is there a benefit in using functional imaging? Eur Radiol 2005; 15: 1658-66.
8. Fernandez FG, Drebin JA, Linehan DC et al. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Am Surg 2004; 240: 438-47.
9. Flamen P, Stroobants S, van Cutsem E et al. Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D- glucose in recurrent colorectal cancer. J Clin Oncol 1999; 17: 894-901.
10. Fong Y, Cohen AM, Fortner JG et al. Liver resection for colorectal metastases. J Clin Oncol 1997; 15: 938-46.
11. 18F-FDG-PET) in the diagnosis of recurrent rectal cancer. Chirurg 2000; 71: 80-5.
12. Harris M. Monoclonal antibodies as therapeutic agents for cancer. Lancet Oncol 2004; 5: 292-302.
13. Holen KD, Saltz LB. New therapies, new directions: advances in the systemic treatment of metastatic colorectal cancer. Lancet Oncol 2001; 2: 290-7.
14. Hosten N, Kreissig R, Puls R et al. Fusion of CT and PET data: methods and clinical relevance for planning laser-induced thermotherapy of liver metastases. Röfo 2000; 172: 630-5.
15. Huebner RH, Park KC, Shepherd JE et al. A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 2000; 41: 1177-89.
16. Hughes KS, Rosenstein RB, Songhorabodi S et al. Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors. Dis Colon Rectum 1988; 31: 1-4.
17. 18F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making. J Nucl Med 2003; 44: 1784-8.
18. Kinkel K, Lu Y, Both M et al. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 2002; 224: 748-56.
19. Liu FY, Chen JS, Changchien CR et al. Utility of 2-fluoro-2-deoxy-D- glucose positron emission tomography in managing patients of colorectal cancer with unexplained carcinoembryonic antigen elevation at different levels. Dis Colon Rectum 2005; 48: 1900-12.
20. Navarra G, Ayav A, Weber JC et al. Short- and- long term results of intraoperative radiofrequency ablation of liver metastases. Int J Colorectal Dis 2005; 20: 521-8.
21. Nordlinger B, Guiguet M, Vaillant JC et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie. Cancer 1996; 77: 1254-62.
22. Ricke J, Wust P, Wieners G et al. Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation. J Vasc Interv Radiol 2004; 15: 1279-86.
23. 18F-FDG positron emission tomography in preoperative assessment of the liver in patients being considered for curative resection of hepatic metastases from colorectal cancer. Clin Nucl Med 2002; 27: 550-5.
24. 18F-FDG PET on detecting extrahepatic disease. Nuklearmedizin 2004; 43: 135-40.
25. Ruers TJ, Langenhoff BS, Neeleman N et al. Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. J Clin Oncol 2002; 20: 388-95.
26. Scheele J, Stang R, Altendorf-Hofmann A et al. Resection of colorectal liver metastases. World J Surg 1995; 19: 59-71.
27. Schiepers C, Penninckx F, De Vadder N et al. Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging. Eur J Surg Oncol 1995; 21: 517-22.
28. Schlag PM, Amthauer H, Stroszczynski C et al. Influence of positron emission tomography on surgical therapy planning in recurrent colorectal cancer. Chirurg 2001; 72: 995-1002.
29. 18F- fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making? Am J Surg 2000; 180: 1-5.
30. 18F fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases. Br J Surg 2005: 92: 362-9.
31. 18F-fluorodeoxyglucose in management of recurrent colorectal cancer. Arch Surg 1999; 134: 503-11.
32. Vitola JV, Delbeke D, Sandler MP et al. Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg 1996; 171: 21-6.
33. Vogl TJ, Straub R, Eichler K et al. Colorectal carcinoma metastases in liver: laser-induced interstitial thermotherapy-local tumor control rate and survival data. Radiology 2004; 230: 450-8.
34. Wallace JR, Christians KK, Quiroz FA et al. Ablation of liver metastasis: is preoperative imaging sufficiently accurate? J Gastrointest Surg 2001; 5: 98-107.